Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 635 of 6351
-
Stem cell particles aim to heal painful Crohn's fistulas
Disease control Recruiting nowThis is a double-blind, randomized, placebo-controlled, sequential cohort, ascending dose clinical trial to evaluate the safety and determine the efficacy of ascending doses of DB-3Q for the treatment of Perianal Fistulizing Crohn's Disease.
Phase 2 • Sponsor: Direct Biologics, LLC • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New drug aims to kickstart transplanted kidneys faster
Disease control Recruiting nowThe primary objective of this study is to demonstrate the efficacy of ravulizumab vs placebo in reducing the severity of DGF as measured by time to freedom from dialysis in adult participants who are at high risk of DGF after undergoing transplant of deceased donor kidney.
Phase 3 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
A handful of pecans a day: Nature's sun shield?
Prevention OngoingThe purpose of this study is to determine if daily consumption of 2 oz of pecans compared to 3.5 oz pretzel snacks for 12 weeks will 1) contribute to the body's ability to protect itself from oxidative damage (caused by oxygen radicals created by ultraviolet (UV) B light) by eval…
Sponsor: University of California, Los Angeles • Aim: Prevention
Last updated Aug 02, 2026 00:00 UTC
-
Can a simple gas save lives after heart surgery? major trial launches
Disease control Recruiting nowCardiac surgery is a procedure that is commonly performed worldwide. Despite these technological advances, cardiac surgery remains a high-risk surgery. Among post-operative complications, acute kidney injury, respiratory failure, myocardial infarction, and stroke as well as cogni…
Phase 3 • Sponsor: Xijing Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New implant aims to stop urine leakage in men
Disease control Recruiting nowProspective, multicenter, single-arm study
Sponsor: UroMems SAS • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New hope for rare lymphoma: duvelisib faces off against standard chemo
Disease control Recruiting nowThe study will evaluate the progression-free survival benefit of duvelisib monotherapy as compared to investigator's choice of gemcitabine or bendamustine in participants with relapsed/refractory nodal T cell lymphoma with TFH phenotype.
Phase 3 • Sponsor: SecuraBio • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New immunotherapy combo aims to treat leukemia without chemo
Disease control Recruiting nowThis trial is a non-blinded, single-center, open-label, single-arm clinical study to evaluate a full-course immunotherapy regimen in patients with B-cell acute lymphoblastic leukemia (B-ALL). The study population includes newly diagnosed patients who are unfit for or decline inte…
Phase 2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New triple therapy aims to wipe out hidden CLL cells
Disease control Recruiting nowThe purpose of this study is to determine the proportion of participants who achieve undetectable measurable residual disease (uMRD) in previously untreated chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).
Phase 2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
New combo therapy aims to boost remission in IDH2-Mutated AML
Disease control Recruiting nowThis phase II MyeloMATCH treatment trial studies how well ASTX727 and venetoclax plus enasidenib works compared to ASTX727 and venetoclax alone for the treatment of older patients with newly diagnosed acute myeloid leukemia (AML) or younger patients who are considered unfit for s…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New antibody drug aims to calm painful skin condition
Disease control OngoingThe study is a Phase 2, multi-center, randomized, double-blind, placebo-controlled study to evaluate the effects of tibulizumab over 16 weeks (Period 1) in adults with hidradenitis suppurativa, followed by a 16-week open-label extension period in which all participants will recei…
Phase 2 • Sponsor: Zura Bio Inc • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Can a partner boost PTSD recovery? new trial aims to find out
Symptom relief Recruiting nowPTSD occurs in up to 17% of post-9/11 US Service Members and is associated with long-term functional impairment, family problems, unemployment, and suicidality. Trauma-focused therapies (TFTs), such as Prolonged Exposure (PE), result in significant relief for many. Yet, TFTs are …
Sponsor: United States Department of Defense • Aim: Symptom relief
Last updated Jun 27, 2026 07:57 UTC
-
New drug duo targets tough lymphoma
Disease control Recruiting nowPART 1: 1. To explore the safety of ZG005 in combination with Gecacitinib in patients with relapsed or refractory lymphoma. 2. To determine the recommended Phase II dosing regimen for relapsed or refractory lymphoma. PART 2: To evaluate the efficacy of ZG005 in combination wit…
Phase 1/2 • Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Can a new injection shrink nasal polyps and restore easy breathing?
Disease control CompletedThis is a multi-center, randomized, double blind, placebo-controlled Phase II study to evaluate the efficacy and safety of CM512, and to observe the life quality of subjects, the Pharmacokinetics, Pharmacodynamics and immunogenicity of CM512 in patients with chronic rhinosinusiti…
Phase 2 • Sponsor: Beijing Keymed Biosciences Co., Ltd. • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
New brain stent aims to keep arteries open and prevent strokes
Disease control Recruiting nowThis investigation is a prospective, multicenter, randomized controlled, non-inferiority clinical trial, to evaluate the safety and efficacy of the investigational device against alternative models/specifications of the control device. The study will be conducted across multiple …
Phase 3 • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New chickenpox shot shows promise in toddler trial
Vaccine Recruiting nowThe purpose of this study is to evaluate the immune response and safety of GSKs investigational varicella vaccine (VNS Vaccine) compared to an already approved varicella vaccine, Varivax (VV), when administered as second dose to healthy children. 3 months after first dose at 12 t…
Phase 3 • Sponsor: GlaxoSmithKline • Aim: Vaccine
Last updated Jun 27, 2026 13:00 UTC
-
New daily pill could help shed pounds without injections
Disease control CompletedIt is a multicenter, randomized, double-blind, placebo-controlled phase II clinical trial to evaluate the safety and efficacy of DA-302168S tablets in overweight and obese adults.
Phase 2 • Sponsor: Chendu DIAO Pharmaceutical Group CO., LTD. • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
New heart valve study could offer seniors a Surgery-Free option
Disease control Recruiting nowThe study objective is to demonstrate that the clinical outcomes of the Myval balloon-expandable THV series are non-inferior to those of SAVR in patients with symptomatic severe aortic stenosis aged 65 to 75 years.
Sponsor: Ceric Sàrl • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Immunotherapy combo shows promise in bladder cancer trial
Disease control Recruiting nowThe Phase IIIb NIAGARA-2 study aims to expand on the data from the Phase III NIAGARA study by investigating perioperative durvalumab in combination with investigator-selected cisplatin-based neoadjuvant chemotherapy (either ddMVAC or gemcitabine/cisplatin) in a clinical practice …
Phase 3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
A simple mesh could stop a common complication after liver transplants
Prevention By invitation onlyA multicenter prospective, consecutive case series study, on the use of a bio-absorbable mesh for prevention of incisional hernia, in high risk patients, after orthotopic liver transplantation.
Sponsor: University of Rome Tor Vergata • Aim: Prevention
Last updated Aug 06, 2026 00:00 UTC
-
New ultrasound dye could stop unnecessary emergency surgeries for ovarian torsion
Diagnosis Recruiting nowAdnexal torsion is the rotation of the ovary around its vascular axis resulting, in the absence of treatment, ischemia that can lead to peritonitis by necrosis or impaired fertility. It is a gynecological emergency affecting 3% of women of childbearing age, including from adolesc…
Phase 3 • Sponsor: Central Hospital, Nancy, France • Aim: Diagnosis
Last updated Jun 27, 2026 12:05 UTC